Evaluation of Clinical Profile and Various Treatment Modalities in Oral Sub Mucous Fibrosis in North India: Our Experience

2022 ◽  
Author(s):  
Pankaj Kumar Verma ◽  
Amit Kumar Rana ◽  
Swati Tripathi ◽  
Shivesh Kumar ◽  
Deepak Upadhyay
Keyword(s):  
Clinical Profile ◽  
North India ◽  
Treatment Modalities ◽  
Oral Sub Mucous Fibrosis

scholarly journals Substance-dependent women attending a de-addiction center in North India: Sociodemographic and clinical profile

2005 ◽  
Vol 59 (7) ◽  
pp. 283 ◽  
Author(s):  
D Basu ◽  
S Grover ◽  
AS Irpati ◽  
BS Saluja ◽  
SK Mattoo
Keyword(s):  
Clinical Profile ◽  
North India ◽  
Substance Dependent

scholarly journals Risk factors and clinical profile of ischemic heart disease in north India

2018 ◽  
Vol 4 (6) ◽  
pp. 846-851
Author(s):  
Ashish Akshay Bedi ◽  
Ankit Gaur ◽  
Sourabh Kosey ◽  
Deepanshu Kumar Chitra ◽  
Kuldeep Singh ◽  
...  
Keyword(s):  
Risk Factors ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Clinical Profile ◽  
Ischemic Heart ◽  
North India

A clinical profile and outcome of patients with acute pancreatitis: A prospective study in North India

2018 ◽  
Vol 8 (3) ◽  
pp. 132 ◽  
Author(s):  
Neha Jindal ◽  
Yamandeep Chauhan ◽  
RamKumar Verma ◽  
PraveenKumar Tyagi ◽  
Madhulata Rana ◽  
...  
Keyword(s):  
Acute Pancreatitis ◽  
Prospective Study ◽  
Clinical Profile ◽  
North India ◽  
A Prospective Study

A study of type, pattern, and clinical profile of retained musculoskeletal foreign bodies of extremities in a tertiary care hospital of North India

2018 ◽  
Vol 6 (3) ◽  
pp. 95
Author(s):  
GaneshSingh Dharmshaktu ◽  
Binit Singh ◽  
Alamgir Jhan ◽  
Aanshu Singhal ◽  
ShailendraSingh Bhandari
Keyword(s):  
Foreign Bodies ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Clinical Profile ◽  
North India ◽  
Care Hospital ◽  
Type Pattern

scholarly journals Clinical Profile and outcome of Pediatric ALL with CNS involvement at diagnosis: Data from a tertiary care centre in North India.

2019 ◽  
Vol 4 (2) ◽  
pp. S24
Author(s):  
Alka Yadav ◽  
Sanjiv Nanda ◽  
Jaya Shankar Kaushik ◽  
Alok Kumar Khanna ◽  
Arpit Kumar
Keyword(s):  
Tertiary Care ◽  
Clinical Profile ◽  
North India ◽  
Care Centre ◽  
Cns Involvement ◽  
Tertiary Care Centre ◽  
Pediatric All

scholarly journals PC3 - 128 Clinical Profile and Treatment Outcomes of Patients with Primary CNS Lymphoma in a Tertiary Hospital in the Philippines: An Eight-Year Retrospective Review

2016 ◽  
Vol 43 (S4) ◽  
pp. S20-S20
Author(s):  
M.C. Concepcion Sales
Keyword(s):  
Survival Rate ◽  
Combination Chemotherapy ◽  
Single Agent ◽  
Primary Cns Lymphoma ◽  
B Cell Lymphoma ◽  
The Philippines ◽  
Clinical Profile ◽  
Treatment Modalities ◽  
Cns Lymphoma ◽  
Female Ratio

Primary CNS Lymphoma (PCNSL) is an unusual extranodal form of Non-Hodgkin’s lymphoma with a locally aggressive course but a rare tendency to disseminate systemically. It has been documented in that the clinical characteristics and response to treatment among Asians is comparable to the Western population yet no studies done locally are available. Objectives: This study aims to determine the clinico-pathologic profile of patients diagnosed with PCNSL seen at Philippine General Hospital (PGH) from January 2006 to September, 2014 and to evaluate the patients’ response to the following treatment modalities: 1) Combination chemotherapy 2) Chemo-RT 3) Single agent chemotherapy and 4) no specific anti-lymphoma treatment. Methodology: This is a descriptive and retrospective study that included all cases of histologically-proven PCNSL seen at the PGH from January 2006 to September, 2014. The clinical profile, imaging studies and biopsy findings were obtained from the patient records. The survival rates at the end of one and two years of diagnosis were computed. Results and Conclusion. Among patients diagnosed with PCNSL at PGH, there is a higher incidence of PCNSL among males with a male to female ratio of 1.4:1 and have a younger onset with a median age of 50.2 years. Most patients presented with signs of increase ICP and majority had solitary cortical lesions with histopathologic diagnosis of diffuse large B cell lymphoma. Patients who did not undergo any form of treatment had a mean survival of 10 months. Immunocompromised patients had a shorter life-span with a mean survival of 7.5 months. Treatment of combination chemotherapy with HD-MTX and Rituximab had the most favorable outcome followed by HD-MTX only with a 2 year survival rate of 100% and 66% respectively while patients who underwent chemo-RT had a 2 year survival rate of 33% with a high incidence of neurocognitive delay.

Sign in / Sign up

Export Citation Format

Share Document